That seems to sum up medical advancement i guess. It works both ways as the FDA or whoever make it so expensive to get a drug to market, though at the same time we absolutely need to be sure of safety. Medical costs are just spiralling though. Pyc could quite possibly have developed imyc as a great cancer treatment but it got dropped pretty much for financial reasons it seems. Sad world. But at least pyc is rising and apparently holding for the first time in a decade.
Ann: Successful Competitive Drug Evaluation in Animals, page-18
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 11.0¢ | 10.0¢ | $184.6K | 1.761M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 51807 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 680221 | 5 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |